Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA

Delayed Quote. Delayed  - 08/23 10:00:00 pm
12.25 USD   -1.92%
08/01 VANDA PHARMACEU : HETLIOZ® is Now Available for the Treatment of Non..
07/27 VANDA PHARMACEU : reports 2Q loss
07/27 VANDA PHARMACEU : Reports Second Quarter 2016 Financial Results
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/17/2016 08/18/2016 08/19/2016 08/22/2016 08/23/2016 Date
12.36(c) 12.39(c) 12.19(c) 12.49(c) 12.25 Last
309 605 264 230 355 327 441 260 586 512 Volume
-1.51% +0.24% -1.61% +2.46% -1.92% Change
More quotes
Financials ($)
Sales 2016 147 M
EBIT 2016 -31,2 M
Net income 2016 -25,9 M
Debt 2016 -
Yield 2016 -
Sales 2017 166 M
EBIT 2017 -4,55 M
Net income 2017 4,03 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 3,69x
Capi. / Sales2017 3,25x
Capitalization 541 M
More Financials
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.Its products portfolio includes HETLIOZ, Fanapt and Tradipitant, Trichostatin and AQW051.Vanda Pharmaceuticals was founded by... 
More about the company
Surperformance© ratings of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on VANDA PHARMACEUTICALS INC.
08/18 VANDA PHARMACEUTICALS : "Treating Neurodegenerative Disease with Fenofibrate and..
08/11 VANDA PHARMACEUTICALS : Assigned Patent
08/01 VANDA PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (fo..
08/01 VANDA PHARMACEUTICALS : HETLIOZ® is Now Available for the Treatment of Non-24-Ho..
07/28 VANDA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condit..
07/27 VANDA PHARMACEUTICALS : reports 2Q loss
07/27 VANDA PHARMACEUTICALS INC. : Results of Operations and Financial Condition, Fina..
07/27 VANDA PHARMACEUTICALS : Reports Second Quarter 2016 Financial Results
07/12 VANDA PHARMACEUTICALS : to Announce Second Quarter 2016 Financial Results on Jul..
06/30 VANDA PHARMACEUTICALS : to Present at the JMP Securities Life Sciences Conferenc..
More news
Sector news : Bio Therapeutic Drugs
08:49aDJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08:49aDJPFIZER : to Acquire Key Drug -- WSJ
08/22DJPfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
08/22DJPFIZER : to Acquire Medivation in Deal Worth $14 Billion -- 4th Update
08/22DJPFIZER : to Acquire Medivation in Deal Worth $14 Billion -- 3rd Update
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
08/20 Tracking John Paulson's Paulson & Company Portfolio - Q2 2016 Update
08/19 BIOTECH FORUM DAILY DIGEST : Portola's Big Disappointment, Cerulean Implodes, Sp..
07/27 Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q2 2016 Results - ..
07/27 Vanda Pharmaceuticals beats by $0.24, revenue in-line
07/26 Notable earnings after Wednesday?s close
Advertisement
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Technical analysis trends VANDA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 17,3 $
Spread / Average Target 38%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mihael Hristos Polymeropoulos President, Chief Executive Officer & Director
H. Thomas Watkins Chairman
James Patrick Kelly Chief Financial Officer, Treasurer & Senior VP
Paolo Baroldi Chief Medical Officer & Senior Vice President
Howard H. Pien Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
VANDA PHARMACEUTICALS ..34.16%541
AMGEN, INC.7.40%130 477
GILEAD SCIENCES, INC.-20.03%106 787
CELGENE CORPORATION-4.64%88 518
REGENERON PHARMACEUTIC..-22.88%44 082
VERTEX PHARMACEUTICALS..-19.76%25 016
More Results